about
Breast cancer stroma frequently recruits fetal derived cells during pregnancyTowards an optical biopsy for the diagnosis of breast cancer in vivo by endogenous fluorescence spectroscopy.Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary).Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohortImportance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patientsEpstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeGWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patientsHigher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trialHigh inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study.Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer.A whole-genome sequence and transcriptome perspective on HER2-positive breast cancersBreast elasticity: principles, technique, results: an update and overview of commercially available software.Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature.Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency: is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions?Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients.Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography.Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries.Strategies for cancer gene therapy using adenoviral vectors.The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients.
P50
Q21195222-4C335421-97FC-4DC6-911E-45D8E7586292Q30938640-6100B174-9548-4FD5-B1B4-1A4AD03E8973Q33310987-6ACBBD34-743D-4E4A-A4EC-710F1B800493Q33731346-0E5814E7-20B6-4C1D-9C86-91C88E72111FQ33919243-074B5C92-831A-48D5-BDB2-A02C8B800148Q34301695-8E4203AF-B0EA-4B02-9186-A6EB7B72418EQ34335864-86900559-F1A6-47DA-AFED-CE2D07D925B5Q36169701-33DA41AA-D643-42A0-BD78-770473631F94Q36412529-C7B2606F-5B10-47C0-85C2-7095CD3C2330Q36600509-0DDEA1C5-72C4-47C1-AB30-5C14A18F7553Q36648916-ADD3306B-0AEF-4E8C-ADF6-3BC9B67CDA6EQ37099507-4F18B954-E5CB-4BB9-8768-B747C948C837Q37996737-62DC85C0-69D6-45BE-86FD-B954E3A84177Q38044957-E87CA183-B8BF-42F9-8C8B-9CB1E9B764B0Q38150470-2176169D-DDF8-44E6-8F00-AF36876ECC48Q38403441-7CA28D09-4E67-4CB4-9040-CA27954C2A4FQ38613552-AC7739BE-F01B-4E1B-9813-5470E2062D5FQ38796138-1C7C23C6-CF41-4FDD-80B8-919ECBC87389Q38877656-94619ABE-A6BA-4D26-9D1F-4B0DEC07D377Q39772495-C00F8558-C6F4-424E-B9E3-B94A71E1D08CQ40372047-A7425AA0-EFF8-4DBD-B96D-16CBF4EE750FQ40382207-2D46D75A-53ED-4741-9AE6-B6E080B5ABFDQ41063900-E046E2C1-3477-42BA-AEAF-C87E82919E74Q41625138-20601288-761F-4917-88BF-D96D690C8059Q42282776-0990DFA4-5552-4740-BEF2-0D30A89EE410
P50
description
onderzoeker
@nl
name
Marie-Christine Mathieu
@ast
Marie-Christine Mathieu
@en
Marie-Christine Mathieu
@es
Marie-Christine Mathieu
@nl
Marie-Christine Mathieu
@sl
type
label
Marie-Christine Mathieu
@ast
Marie-Christine Mathieu
@en
Marie-Christine Mathieu
@es
Marie-Christine Mathieu
@nl
Marie-Christine Mathieu
@sl
prefLabel
Marie-Christine Mathieu
@ast
Marie-Christine Mathieu
@en
Marie-Christine Mathieu
@es
Marie-Christine Mathieu
@nl
Marie-Christine Mathieu
@sl